C1QL1 inhibits breast cancer through the HSP90α/VCP-ERS/UPR axisNingning Zhang(Chongqing University), Xiaohua Zeng(Chongqing Cancer Hospital)Experimental & Molecular MedicineJune 30, 202510.1038/s12276-025-01486-1Cited by 1SaveCiteExport RISWatch citationsRelated PapersPyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial|BMJ|2023|82Iron accumulation in ovarian microenvironment damages the local redox balance and oocyte quality in aging mice|Redox Biology|2024|60